PriceTargets.com logo

Envoy Medical - COCH Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $8.00
  • Forecasted Upside: 510.69%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$1.31 As of 04/1/2025 05:00 PM ET
▲ +0.01 (0.77%)

This chart shows the closing price for COCH by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
FebMar$1.31Closing price on 04/01/25:
Get New Envoy Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for COCH and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for COCH

Analyst Price Target is $8.00
▲ +510.69% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Envoy Medical in the last 3 months. The average price target is $8.00, with a high forecast of $9.00 and a low forecast of $6.00. The average price target represents a 510.69% upside from the last price of $1.31.

This chart shows the closing price for COCH for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart
3/246/249/2412/244/254/26$0.91$2.93$4.96$6.98$9Closing price on 04/01/25: $1.31High$9.00Average$8.00Low$6.00




Current Consensus is Buy

The current consensus among 3 investment analysts is to buy stock in Envoy Medical.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/10/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/8/2024
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/7/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/6/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/4/2024
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/2/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/3/2025
  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/2/2025

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/6/2024Ascendiant Capital MarketsBoost TargetBuy ➝ Buy$8.75 ➝ $9.00
10/14/2024Brookline Capital ManagementInitiated CoverageBuy$9.00
9/3/2024Ascendiant Capital MarketsBoost TargetBuy ➝ Buy$8.50 ➝ $8.75
6/24/2024Ascendiant Capital MarketsInitiated CoverageBuy$8.50
4/3/2024Lake Street CapitalBoost TargetBuy ➝ Buy$3.00 ➝ $6.00
12/21/2023Northland SecuritiesInitiated CoverageOutperform
11/28/2023Lake Street CapitalInitiated CoverageBuy$3.00
(Data available from 4/2/2020 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/4/2024
  • 3 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/4/2024
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/3/2024
  • 0 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/3/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/2/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/1/2025
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/3/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/2/2025

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Envoy Medical logo
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Read More

Today's Range

Now: $1.31
Low: $1.27
High: $1.35

50 Day Range

MA: $1.46
Low: $1.30
High: $1.67

52 Week Range

Now: $1.31
Low: $1.21
High: $7.20

Volume

7,298 shs

Average Volume

90,137 shs

Market Capitalization

$26.52 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.4

Frequently Asked Questions

What sell-side analysts currently cover shares of Envoy Medical?

The following equities research analysts have issued reports on Envoy Medical in the last twelve months: Ascendiant Capital Markets, Brookline Capital Management, and Lake Street Capital.
View the latest analyst ratings for COCH.

What is the current price target for Envoy Medical?

0 Wall Street analysts have set twelve-month price targets for Envoy Medical in the last year. Their average twelve-month price target is $8.00, suggesting a possible upside of 510.7%. Ascendiant Capital Markets has the highest price target set, predicting COCH will reach $9.00 in the next twelve months. Lake Street Capital has the lowest price target set, forecasting a price of $6.00 for Envoy Medical in the next year.
View the latest price targets for COCH.

What is the current consensus analyst rating for Envoy Medical?

Envoy Medical currently has 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe COCH will outperform the market and that investors should add to their positions of Envoy Medical.
View the latest ratings for COCH.

What other companies compete with Envoy Medical?

Other companies that are similar to Envoy Medical include Monogram Orthopaedics, FONAR, InspireMD, Sensus Healthcare and Edap Tms. Learn More about companies similar to Envoy Medical.

How do I contact Envoy Medical's investor relations team?

Envoy Medical's physical mailing address is 4875 White Bear Parkway, White Bear Lake, MN 55110, United States. The company's listed phone number is 877-900-3277 and its investor relations email address is scotta@coreir.com. The official website for Envoy Medical is www.envoymedical.com. Learn More about contacing Envoy Medical investor relations.